Key points are not available for this paper at this time.
Microbiota represents the entire microbial community present in the gut host. It serves several functions establishing a mutualistic relation with the host. Latest years have seen a burst in the number of studies focusing on this topic, in particular on intestinal diseases. In this scenario, Proteobacteria are one of the most abundant phyla, comprising several known human pathogens. This review highlights the latest findings on the role of Proteobacteria not only in intestinal but also in extraintestinal diseases. Indeed, an increasing amount of data identifies Proteobacteria as a possible microbial signature of disease. Several studies demonstrate an increased abundance of members belonging to this phylum in such conditions. Major evidences currently involve metabolic disorders and inflammatory bowel disease. However, more recent studies suggest a role also in lung diseases, such as asthma and chronic obstructive pulmonary disease, but evidences are still scant. Notably, all these conditions are sustained by various degree of inflammation, which thus represents a core aspect of Proteobacteria-related diseases.
Building similarity graph...
Analyzing shared references across papers
Loading...
Gianenrico Rizzatti
Agostino Gemelli University Polyclinic
Loris Riccardo Lopetuso
Università Cattolica del Sacro Cuore
Giulia Gibiino
Azienda-Unita' Sanitaria Locale Di Cesena
SHILAP Revista de lepidopterología
BioMed Research International
Agostino Gemelli University Polyclinic
Building similarity graph...
Analyzing shared references across papers
Loading...
Rizzatti et al. (Sun,) studied this question.
synapsesocial.com/papers/69d8379938c00da8b4bed8b8 — DOI: https://doi.org/10.1155/2017/9351507
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: